A novel synthetic derivative of human erythropoietin designed to bind to glycosaminoglycans

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

(2010) J. D. Rizzo et al.   BLOOD

Phase 3 trial of everolimus for metastatic renal cell carcinoma

(2010) Robert J. Motzer et al.   CANCER

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

(2010) Takuya Ozawa et al.   CIRCULATION JOURNAL

Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2010) Ilka Ott et al.   Circulation-Cardiovascular Interventions

A single dose of erythropoietin in ST-elevation myocardial infarction

(2010) A. A. Voors et al.   EUROPEAN HEART JOURNAL

Erythropoietin Receptor Signaling Mitigates Renal Dysfunction-Associated Heart Failure by Mechanisms Unrelated to Relief of Anemia

(2010) Atsushi Ogino et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thrombocytosis in EPO-Treated Dialysis Patients May Be Mediated by EPO Rather Than Iron Deficiency

(2009) Nosratola D. Vaziri   AMERICAN JOURNAL OF KIDNEY DISEASES

"Antimyeloangiogenic" Therapy for Cancer by Inhibiting PlGF

(2009) S. Loges et al.   CLINICAL CANCER RESEARCH

Erythropoietin in Cancer Patients

(2008) John A. Glaspy   Annual Review of Medicine

Repression via the GATA box is essential for tissue-specific erythropoietin gene expression

(2008) N. Obara et al.   BLOOD